Company / AR per Share
BioMarin Pharmaceutical AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$4.72
FY2025
5-year range
$2.05 / $4.72
FY2021-FY2025
Trend
+36.4%
vs FY2024
Sector context
#20 of 113
Health Care
What the data says
BioMarin Pharmaceutical's ar per share of $4.72 is higher than 82% of companies in the Health Care sector (FY2025). AR per Share has increased for 4 consecutive years, from $2.05 in FY2021 to $4.72 in FY2025.
Based on SEC 10-K filings.
4.72 in FY2025 with a 5-year CAGR of +13.9%. Top quartile in the Health Care sector.
Improved from $3.36 to $4.72 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +24.0%
- 5-Year CAGR
- +13.9%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 113This company $4.72 Sector average $28.83
▼
-83.6% below sector average
Key checks
Key Insights
- BioMarin Pharmaceutical's ar per share has grown for 4 consecutive years.
- In FY2025, ar per share increased 36.4% year-over-year.
- Ranks #20 out of 113 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.72 | +36.4% |
| FY2024 | $3.46 | +3.1% |
| FY2023 | $3.36 | +35.7% |
| FY2022 | $2.48 | +20.6% |
| FY2021 | $2.05 | -16.7% |
| FY2020 | $2.47 | +17.6% |
| FY2019 | $2.10 | +9.2% |
| FY2018 | $1.92 | +29.3% |
| FY2017 | $1.49 | +19.2% |
| FY2016 | $1.25 | +22.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026